Filing
Spy
Filing
Spy
Home
About
KITE
Kite Pharma Inc
Clinical-stage biopharmaceutical company developing cancer immunotherapies
CUSIP: 49803L109
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2015 Q2
9 of 10 quarters
Total Value
$41.30M
Total Shares
677.3K
Net Share Change
+677.3K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$41.30M
677.3K
0.2%
NEW
Viking Global Investors
$41.30M
677.3K shares
NEW
KITE — Kite Pharma Inc - FilingSpy